Fremont CA 银屑病临床试验
5项针对 银屑病的研究正在 Fremont及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
招募中4 期
- Center For Dermatology Clinical Research, Inc., Fremont
A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis
招募中3 期
- Center For Dermatology Clinical Research, Inc., Fremont
Open Label Study to Investigate the Safety and Efficacy of Ponesimod in Moderate-to-Severe Chronic Plaque Psoriasis
招募中3 期
- Vanda Investigational Site, Fremont
A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Palmoplantar Pustulosis
招募中3 期
- Ppp001 50176, Fremont
A Study to Evaluate D-2570 in Participants With Moderate to Severe Plaque Psoriasis
招募中2 期
- Study Center, Fremont
其他城市的 银屑病试验
- Trenton, NJ7 项研究
- Philadelphia, PA6 项研究
- Cleveland, OH6 项研究
- Huntington Beach, CA5 项研究
- San Antonio, TX5 项研究
- New York City, NY5 项研究
- Newton, MA5 项研究
- Houston, TX4 项研究
- Birmingham, AL4 项研究
- Sacramento, CA3 项研究
- Miami, FL3 项研究
- Indianapolis, IN3 项研究
Fremont的其他研究
数据来自 ClinicalTrials.gov，检索日期：2026年11月15日。每项研究自行设定入选标准，由研究团队决定谁能参与。